{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:06:56Z","timestamp":1790942816511,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jaci.2011.04.037","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T14:18:16Z","timestamp":1307110696000},"page":"147-152.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Mast cell activation syndrome: A\u00a0newly recognized disorder with systemic clinical manifestations"],"prefix":"10.1016","volume":"128","author":[{"given":"Matthew J.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norton J.","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.04.037_bib1","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3748\/wjg.v13.45.i6041","article-title":"Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome","volume":"13","author":"Wang","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2011.04.037_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","article-title":"Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2011.04.037_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O\u2019Sullivan","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaci.2011.04.037_bib4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/BF01303164","article-title":"Terminal ileal mucosal mast cells in irritable bowel syndrome","volume":"38","author":"Weston","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2011.04.037_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","article-title":"Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome","volume":"137","author":"Buhner","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2011.04.037_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3748\/wjg.v10.i3.309","article-title":"Key role of mast cells and their major secretory products in inflammatory bowel disease","volume":"10","author":"He","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2011.04.037_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2036.2004.01974.x","article-title":"Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis","volume":"20","author":"Nakajima","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2011.04.037_bib8","doi-asserted-by":"crossref","first-page":"G178","DOI":"10.1152\/ajpgi.2001.280.2.G178","article-title":"Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins","volume":"280","author":"Pothoulakis","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2011.04.037_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2982.2005.00685.x","article-title":"Functional gastrointestinal disorders and mast cells: implications for therapy","volume":"18","author":"Barbara","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaci.2011.04.037_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","article-title":"Mastocytosis: mediator-related signs and symptoms","volume":"127","author":"Castells","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.04.037_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0016-5085(88)80012-X","article-title":"Gastrointestinal dysfunction in systemic mastocytosis. A\u00a0prospective study","volume":"95","author":"Cherner","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2011.04.037_bib12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.04.037_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2011.04.037_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.04.037_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.04.037_bib16","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2009.08.047","article-title":"Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report","volume":"137","author":"Spiegel","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2011.04.037_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2011.04.037_bib18","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","article-title":"Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis","volume":"31","author":"Hahn","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2011.04.037_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0378-6323.39724","article-title":"Dermatographism","volume":"74","author":"Bhute","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2011.04.037_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(85)90454-1","article-title":"Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial","volume":"78","author":"Frieri","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2011.04.037_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production","volume":"147","author":"Butterfield","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.04.037_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","article-title":"Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea","volume":"130","author":"Jakate","year":"2006","journal-title":"Arch Pathol Lab Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911006750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911006750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:27:18Z","timestamp":1758788838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911006750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0091674911006750"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.04.037","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12678956.13937054","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell activation syndrome: A\u00a0newly recognized disorder with systemic clinical manifestations","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}